Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human parvovirus B19.

Erik D Heegaard1, Kevin E Brown

  • 1Department of Clinical Microbiology, University State Hospital, Rigshospitalet, Copenhagen, Denmark.

Clinical Microbiology Reviews
|July 5, 2002
PubMed
Summary

Parvovirus B19 (B19) causes various illnesses depending on host immunity and blood status. Treatments like immunoglobulin and potential vaccines offer hope for managing B19 infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

EBioMedicine·2026
Same author

Seroprevalence of measles antibodies in children with cancer: results of a 2024 UK service evaluation.

Archives of disease in childhood·2025
Same author

Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents.

iScience·2023
Same author

Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK.

The Lancet. Child & adolescent health·2023
Same author

COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study.

The Journal of infection·2023
Same author

Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study.

The Pediatric infectious disease journal·2023

Area of Science:

  • Virology
  • Immunology
  • Hematology

Background:

  • Parvovirus B19 (B19), discovered in 1974, is the sole human-pathogenic member of the Parvoviridae family.
  • Despite challenges in cell culture propagation, significant insights into B19 pathophysiology, cellular receptor (P antigen), and immune system control have been gained.

Observation:

  • B19 infection manifestations are diverse, influenced by host immunologic and hematologic status.
  • In healthy individuals, B19 causes erythema infectiosum and polyarthropathy.
  • In immunocompromised individuals or those with hemolytic disorders, B19 can lead to aplastic crisis, pure red cell aplasia, chronic anemia, or fetal complications like hydrops fetalis.

Findings:

  • Diagnosis relies on detecting specific antibodies (ELISA) or viral DNA (PCR, dot blot).
  • Treatment with immunoglobulin effectively reduces viral load and resolves anemia in persistent infections.
  • Early vaccine trials demonstrate promising outcomes.

Implications:

  • Understanding B19's varied clinical presentations is crucial for accurate diagnosis and management.
  • Effective treatments and potential vaccines are vital for mitigating B19-associated morbidity and mortality.
  • Further research into B19 pathogenesis and host interactions may reveal new therapeutic strategies.

Related Experiment Videos